GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Discovery Capital Management LLC CT

Discovery Capital Management LLC CT lowered its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 76.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 50,000 shares of the company’s stock after selling 160,550 shares during the period. Discovery Capital Management LLC CT’s holdings in GE HealthCare Technologies were worth $3,909,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Cathy Pareto & Associates Inc. acquired a new stake in GE HealthCare Technologies in the fourth quarter worth about $670,000. Principal Financial Group Inc. lifted its stake in shares of GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock worth $94,780,000 after acquiring an additional 19,010 shares during the period. Everence Capital Management Inc. boosted its holdings in shares of GE HealthCare Technologies by 118.2% in the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock valued at $1,475,000 after acquiring an additional 10,220 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its stake in shares of GE HealthCare Technologies by 9.7% during the third quarter. Nomura Asset Management Co. Ltd. now owns 145,996 shares of the company’s stock valued at $13,702,000 after acquiring an additional 12,908 shares during the period. Finally, Apollon Wealth Management LLC raised its holdings in GE HealthCare Technologies by 46.5% during the fourth quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company’s stock worth $1,025,000 after purchasing an additional 4,160 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Wells Fargo & Company increased their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $98.75.

GE HealthCare Technologies Trading Up 0.9 %

GE HealthCare Technologies stock opened at $80.71 on Tuesday. The company has a 50 day moving average price of $86.62 and a 200 day moving average price of $85.81. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The firm has a market capitalization of $36.91 billion, a price-to-earnings ratio of 18.64, a P/E/G ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.23%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.